EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity

Daisy H Luff iD, Edina Schweighoffer, Victor L J Tybulewicz iD

Immunological Reviews · 2026-09 · 342 (1)

DOI: 10.1111/imr.70170 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 17.09.2026. Verfasst von Daisy H Luff und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Francis Crick Institute, London, UK. Hauptthemen laut MEDLINE: Autoimmunity, B-Lymphocytes, Tumor Necrosis Factor Ligand Superfamily Member 13, B-Cell Activating Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Francis Crick Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BAFF and APRIL are TNF superfamily proteins that bind to BAFFR, TACI and BCMA, members of the TNF receptor superfamily. These proteins have both unique and overlapping roles in B cell development and survival and are major therapeutic targets for antibody‐ and B‐cell‐driven pathologies. BAFF and BAFFR are required for development and survival of follicular and marginal zone (MZ) B cells, whereas BAFF and APRIL acting through TACI and BCMA support plasma cell survival. TACI and BCMA can both be cleaved to generate soluble decoy receptors binding to BAFF or APRIL, forming feedback circuits. Thus, loss of TACI leads to an increase in BAFF, resulting in B cell hyperplasia. Recent work showed that TACI is required for MZ B cell development, a finding that has implications for understanding immune dysfunction in humans. Both monoallelic and biallelic loss‐of‐function TACI mutations result in immunodeficiency, potentially due to impaired MZ B cell function. Paradoxically, monoallelic TACI mutations predispose to autoimmunity. We propose this may be due to increased BAFF levels which promote selection of self‐reactive B cell clones into the mature B cell pool, particularly the MZ B cell compartment. A deeper understanding of this ligand‐receptor system is essential for effective therapeutic targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityB-LymphocytesTumor Necrosis Factor Ligand Superfamily Member 13B-Cell Activating FactorB-Cell Activation Factor ReceptorHumansAnimalsTransmembrane Activator and CAML Interactor ProteinB-Cell Maturation AntigenSignal TransductionMutation

Stichwörter der Autor:innen

APRILBAFFBAFFRBCMATACIautoimmunitycommon variable immunodeficiencymarginal zone B cells

Substanzen

Tumor Necrosis Factor Ligand Superfamily Member 13B-Cell Activating FactorB-Cell Activation Factor ReceptorTransmembrane Activator and CAML Interactor ProteinB-Cell Maturation AntigenTNFSF13B protein, human

Autor:innen und Institutionen

  • The Francis Crick Institute, London, UK.

ORCID-Profile: Daisy H Luff, Victor L J Tybulewicz

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Francis Crick Institute
  • Cancer Research UK

Zitieren

APA

Luff, D. H., Schweighoffer, E., & Tybulewicz, V. L. J. (2026). BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity. Immunological Reviews, 342(1). https://doi.org/10.1111/imr.70170

Vancouver

Luff DH, Schweighoffer E, Tybulewicz VLJ. BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity. Immunological Reviews. 2026;342(1). doi:10.1111/imr.70170

BibTeX
@article{Luff2026,
  author = {Luff, Daisy H and Schweighoffer, Edina and Tybulewicz, Victor L J},
  title = {BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity},
  journal = {Immunological Reviews},
  year = {2026},
  volume = {342},
  number = {1},
  doi = {10.1111/imr.70170}
}
Kostenlos starten →